RNA interference-based nanosystems for inflammatory bowel disease therapy

par Guo J, Jiang XJ, Gui SY
Publié 2016

Novel Inhibitor-Based Therapies for Thyroid Cancer—An Update

par Maciej Ratajczak, Damian Gaweł, Marlena Godlewska
Publié 2021

Her2-Positive Cancers and Antibody-Based Treatment: State of the Art and Future Developments

par Serafin Morales, Ariadna Gasol, Douglas Rene Sanchez
Publié 2021

DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma

par Simona Camero, Giulia Vitali, Paola Pontecorvi, Simona Ceccarelli, Eleni Anastasiadou, Francesca Cicchetti, Elisabetta Flex, Silvia Pomella, Matteo Cassandri, Rossella Rota, Francesco Marampon, Cinzia Marchese, Amalia Schiavetti, Francesca Megiorni
Publié 2021

Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives

par Sacha Nahon-Estève, Corine Bertolotto, Alexandra Picard-Gauci, Lauris Gastaud, Stéphanie Baillif, Paul Hofman, Anaïs Groulier, Célia Maschi, Jean-Pierre Caujolle, Sandra Lassalle, Arnaud Martel
Publié 2021

Reactive oxygen species (ROS)-responsive nanoprobe for bioimaging and targeting therapy of osteoarthritis

par Chong Shen, Ming Gao, Haimin Chen, Yanting Zhan, Qiumei Lan, Zhimin Li, Wei Xiong, Zainen Qin, Li Zheng, Jinmin Zhao
Publié 2021

Targeted Therapies in Cancer: To Be or Not to Be, Selective

par Skye Montoya, Deborah Soong, Nina Nguyen, Maurizio Affer, Sailasya P. Munamarty, Justin Taylor
Publié 2021

ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia

par Tatiana E. Bialik, Vladimir I. Vorob'ev, Valerii A. Ionin, Loic Ysebaert, Kamil D. Kaplanov, Larisa P. Mendeleeva, Evgenii A. Nikitin, Vadim V. Ptushkin, Olga S. Samoilova, Elena A. Stadnik
Publié 2021

Antibody Therapies for Large B-Cell Lymphoma

par Novo M, Santambrogio E, Frascione PMM, Rota-Scalabrini D, Vitolo U
Publié 2021

TP53 in Myelodysplastic Syndromes

par Yan Jiang, Su-Jun Gao, Benoit Soubise, Nathalie Douet-Guilbert, Zi-Ling Liu, Marie-Bérengère Troadec
Publié 2021

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Mod...

par Andrea Palicelli, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Giacomo Santandrea, Martina Bonacini
Publié 2021

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma

par L. V. Bolotina
Publié 2020

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment

par Andrea Palicelli, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Valerio Copelli, Giuditta Bernardelli, Giacomo Santandrea, Martina Bonacini
Publié 2021

Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions

par Maliha Khan, Felipe Samaniego, Fredrick B. Hagemeister, Swaminathan P. Iyer
Publié 2021

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients

par Juliette Palle, Laure Hirsch, Alexandra Lapeyre-Prost, David Malka, Morgane Bourhis, Simon Pernot, Elie Marcheteau, Thibault Voron, Florence Castan, Ariane Lacotte, Nadine Benhamouda, Corinne Tanchot, Eric François, François Ghiringhelli, Christelle de la Fouchardière, Aziz Zaanan, Eric Tartour, Julien Taieb, Magali Terme
Publié 2021

Global Market of Monoclonal Antibodies: Sales, Prices, Demand

par D. A. Uvarov
Publié 2021

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma

par Farzaneh Kordbacheh, Camile S. Farah
Publié 2021

Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma

par Xiang Li, Li Zhang, Xiamei Guo, Fei Xie, Cheng Shen, Yali Jun, Chao Luo, Longfei Liu, Xiaojuan Yu, Zhengwei Zhang, Qilong Wang, Yong Gao, Keping Xu
Publié 2021

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

par Giacomo Aimar, Chiara Paratore, Clizia Zichi, Donatella Marino, Elisa Sperti, Andrea Caglio, Teresa Gamba, Francesca De Vita, Massimo Di Maio
Publié 2021